Fortress Biotech stock price
포트리스 바이오테크NASDAQ:FBIO · Nasdaq · Healthcare$2.03-1.93%
2026-10-02 closeLoading chart…
Today's signals · No active technical signal.
Signal details →Fortress Biotech last closed at $2.03 (-1.93%) on 2026-10-02. Listed on Nasdaq. Trailing 12 months PER is 0.7×. Its overall grade ranks 427 of 739 stocks in Healthcare.
About this company
Fortress Biotech last closed at $2.03 (-1.93%) on 2026-10-02. Listed on Nasdaq.
Details →Reported results
Details →
Position in sector
Healthcare · Overall B- · 427/739
Valuation grade B-
Related stocks
- Vertex PharmaceuticalsCompetitor
희귀질환·특수의약품 개발 영역에서 경쟁
- Amicus TherapeuticsCompetitor
희귀질환 치료제 시장에서 경쟁
- PTC TherapeuticsCompetitor
희귀질환·유전자질환 치료제 개발 경쟁
About Fortress Biotech
- What technical signals does Fortress Biotech (FBIO) have?
- Fortress Biotech current technical signals: no active technical signal.
- Is Fortress Biotech a cup-and-handle pattern?
- No. Fortress Biotech has no valid Cup signal right now.
- What published figures are available for Fortress Biotech?
- Market cap: $63.01M. Trailing 12 months PER: 0.7×. Latest quarter PBR: 0.36×. Dividend yield: 0.00%.
Like these rules? Backtest them.
Run this signal on this ticker in the free backtest builder — same window, no install.
Backtest this rule ↗Major stocks in the same sector
2026-10-04 dataset
Turn what you saw on this name into a strategy
Ask Q about Fortress Biotech, or open the plan table on the main site.
From the names you found to a trading rule
Tell Q about the stocks you found to place orders with your conditions.
Quantus Signal · live data · not investment advice · Privacy Policy